Cargando…

Selective blockade of B7‐H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma

Immature myeloid cells including myeloid‐derived suppressor cells (MDSCs) and tumour‐associated macrophages (TAMs) promote tumour growth and metastasis by facilitating tumour transformation and angiogenesis, as well as by suppressing antitumour effector immune responses. Therefore, strategies design...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Liang, Fan, Teng‐Fei, Wu, Lei, Yu, Guang‐Tao, Deng, Wei‐Wei, Chen, Lei, Bu, Lin‐Lin, Ma, Si‐Rui, Liu, Bing, Bian, Yansong, Kulkarni, Ashok B., Zhang, Wen‐Feng, Sun, Zhi‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571514/ https://www.ncbi.nlm.nih.gov/pubmed/28401653 http://dx.doi.org/10.1111/jcmm.13143

Ejemplares similares

Blockade of adenosine A2A receptor enhances CD8(+) T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
por: Ma, Si-Rui, et al.
Publicado: (2017)

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
por: Yu, Guang-Tao, et al.
Publicado: (2015)

T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
por: Liu, Jian‐Feng, et al.
Publicado: (2017)

Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Han-Qi, et al.
Publicado: (2023)

Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
por: Leclerc, Marine, et al.
Publicado: (2019)

Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma
por: Sun, Wei, et al.
Publicado: (2016)

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
por: Hall, Bradford, et al.
Publicado: (2013)

Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma
por: Sun, Zhi-Jun, et al.
Publicado: (2016)

Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
por: Ma, Hailong, et al.
Publicado: (2018)

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts
por: Kato, Ryoji, et al.
Publicado: (2020)

STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment
por: Anderson, Kelvin, et al.
Publicado: (2022)

Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
por: Liu, Jian-Feng, et al.
Publicado: (2018)

STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell
por: Bu, Lin-Lin, et al.
Publicado: (2015)

Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma
por: Fan, Teng-Fei, et al.
Publicado: (2016)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Manukian, Gregor, et al.
Publicado: (2019)

Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
por: Stanam, Aditya, et al.
Publicado: (2016)

Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC)
por: Shi, Liang, et al.
Publicado: (2022)

Mast cell marker gene signature in head and neck squamous cell carcinoma
por: Cai, Zhimou, et al.
Publicado: (2022)

Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
por: Figueiredo, Carlos R., et al.
Publicado: (2018)

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
por: Sullivan, Kevin M, et al.
Publicado: (2023)

An Overview of Antitumour Activity of Polysaccharides
por: Jin, Hongzhen, et al.
Publicado: (2022)

Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma
por: Wang, Lei, et al.
Publicado: (2021)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
por: Valero, Cristina, et al.
Publicado: (2023)

Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Hsieh, Ching-Yun, et al.
Publicado: (2023)

Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses
por: Wang, Qinghong, et al.
Publicado: (2017)

Epidermal Growth Factor Receptor Inhibition Reduces Angiogenesis via Hypoxia-Inducible Factor-1α and Notch1 in Head Neck Squamous Cell Carcinoma
por: Wang, Wei-Ming, et al.
Publicado: (2015)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Vitamin E (α-Tocopherol) Exhibits Antitumour Activity on Oral Squamous Carcinoma Cells ORL-48
por: Zulkapli, Rahayu, et al.
Publicado: (2016)

Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma
por: Chi, Yanyan, et al.
Publicado: (2022)

Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells
por: Gao, Wanfeng, et al.
Publicado: (2019)

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
por: Callejas-Valera, Juan L., et al.
Publicado: (2022)

Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma
por: Xiong, Hong-Gang, et al.
Publicado: (2019)

NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell
por: Zhao, Zhi-Li, et al.
Publicado: (2016)

Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
por: Zhang, Shi-Long, et al.
Publicado: (2023)

Epigenetic therapy with chidamide alone or combined with 5-azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro
por: Li, Zheng, et al.
Publicado: (2022)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_o2pgejjia983hi8im35629cl3v